Neuroscience
Presynaptic neprilysin prevents amyloid pathology
Published in Gene Therapy Weekly, March 18th, 2004
"A local increase in amyloid-beta peptide (Abeta) is closely associated with synaptic dysfunction in the brain in Alzheimer disease. Here, we report on the catabolic mechanism of Abeta at the presynaptic sites. Neprilysin, an Abeta-degrading enzyme expressed by recombinant adeno-associated viral vector-mediated gene transfer, was axonally transported to presynaptic sites through afferent projections of neuronal circuits," scientists writing in the Journal of Neuroscience report.
"This gene transfer abolished the increase in Abeta levels in the hippocampal formations of neprilysin-deficient...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2004-03-18)
More Articles from Gene Therapy Weekly
- Bladder Cancer
Clusterin suppression makes bladder cancer cells more sensitive to cisplatin - Oncolysis
Mutant adenovirus can destroy multidrug-resistant cancer cells - Oncology
Tumors that resist wild-type p53 respond to p53AIP1 gene therapy - Stem-Cell Research
Embryonic stem cells made to overexpress Bcl-XL offer nerve cell protection - Vector Development
HPC/plasmid constructs promote gene transfer to murine kidney cancer - Vector Development
Viral vectors prepared with TROMS extend transgene expression in mice - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
